Wolverine Asset Management »

Effector Therapeutics shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Effector Therapeutics (EFTRW) shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Effector Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Effector Therapeutics held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Effector Therapeutics by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6k 18k 0.15
2023-09-30 $1.4k 19k 0.08
2023-06-30 $2.3k 13k 0.17
2023-03-31 $1.9k 14k 0.13
2022-12-31 $2.5k 16k 0.16
2022-09-30 $2.0k 12k 0.16
2022-06-30 $4.0k 18k 0.22
2022-03-31 $14k 34k 0.41
2021-12-31 $42k 49k 0.86
2021-09-30 $93k 58k 1.60

More positions owned by Wolverine Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ati Note 3.500% 6/1 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Coinbase Global Com Cl A Put Option (COIN)
Amazon Call Option (AMZN)
Royal Caribbean Cruises Put Option (RCL)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
NVIDIA Corporation Call Option (NVDA)
Li Auto Note 0.250% 5/0 (Principal)
Draftkings Note 3/1 (Principal)
Tesla Motors Call Option (TSLA)
Broadcom Call Option (AVGO)

View all positions for Wolverine Asset Management

Top funds holding Effector Therapeutics

Aristeia Capital
Goldman Sachs Group
Whitebox Advisors
MMCAP International Inc. SPC
Parallel Advisors
Millennium Management
III Capital Management
Tenor Capital Management
Sea Otter Advisors
Wolverine Asset Management
UBS Group
Pineridge Advisors

View all funds holding Effector Therapeutics